The unmet need for better risk stratification of non‐proliferative diabetic retinopathy

Diabetic retinopathy is a common microvascular complication of diabetes and remains one of the leading causes of preventable blindness in working‐age people. Non‐proliferative diabetic retinopathy is the earliest stage of diabetic retinopathy and is typically asymptomatic. Currently, the severity of diabetic retinopathy is assessed using semi‐quantitative grading systems based on the presence or absence of retinal lesions. These methods are well validated, but do not predict those at high risk of rapid progression to sight‐threatening diabetic retinopathy; therefore, new approaches for identifying these people are a current unmet need. We evaluated published data reporting the lesion characteristics associated with different progression profiles in people with non‐proliferative diabetic retinopathy. Based on these findings, we propose that additional assessments of features of non‐proliferative diabetic retinopathy lesions may help to stratify people based on the likelihood of rapid progression. In addition to the current classification, the following measurements should be considered: the shape and size of lesions; whether lesions are angiogenic in origin; the location of lesions, including predominantly peripheral lesions; and lesion turnover and dynamics. For lesions commonly seen in hypertensive retinopathy, a detailed assessment of potential concomitant diseases is also recommended. We believe that natural history studies of these changes will help characterize these non‐proliferative diabetic retinopathy progression profiles and advance our understanding of the pathogenesis of diabetic retinopathy in order to individualize management of people with diabetic retinopathy.

[1]  P. Royle,et al.  Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation. , 2015, Health technology assessment.

[2]  J. Olson,et al.  Modelling the cost‐effectiveness of adopting risk‐stratified approaches to extended screening intervals in the national diabetic retinopathy screening programme in Scotland , 2016, Diabetic medicine : a journal of the British Diabetic Association.

[3]  S. Feman The natural history of the first clinically visible features of diabetic retinopathy. , 1994, Transactions of the American Ophthalmological Society.

[4]  External validation of a risk assessment model to adjust the frequency of eye-screening visits in patients with diabetes mellitus. , 2015, Journal of diabetes and its complications.

[5]  G. Nijpels,et al.  Validation of a model to estimate personalised screening frequency to monitor diabetic retinopathy , 2014, Diabetologia.

[6]  K. Shimizu,et al.  Intraretinal neovascularization in diabetic retinopathy. , 1984, Ophthalmology.

[7]  Feman Ss The natural history of the first clinically visible features of diabetic retinopathy. , 1994 .

[8]  H. Ahsan Diabetic retinopathy--biomolecules and multiple pathophysiology. , 2015, Diabetes & metabolic syndrome.

[9]  Xiaodan Jiang,et al.  Risk factors of diabetic retinopathy and sight-threatening diabetic retinopathy: a cross-sectional study of 13 473 patients with type 2 diabetes mellitus in mainland China , 2017, BMJ Open.

[10]  Jonathan Krause,et al.  Grader variability and the importance of reference standards for evaluating machine learning models for diabetic retinopathy , 2017, Ophthalmology.

[11]  Toco Y P Chui,et al.  Classification of human retinal microaneurysms using adaptive optics scanning light ophthalmoscope fluorescein angiography. , 2014, Investigative ophthalmology & visual science.

[12]  Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. , 1991, Ophthalmology.

[13]  Toke Bek,et al.  The relationships between risk factors and the distribution of retinopathy lesions in type 2 diabetes. , 2006, Acta ophthalmologica Scandinavica.

[14]  D. Lackland,et al.  Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. , 2004, Investigative ophthalmology & visual science.

[15]  Stephen J. Aldington,et al.  Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69. , 2004, Archives of ophthalmology.

[16]  Matthew D. Davis,et al.  Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. , 2003, Ophthalmology.

[17]  Armin Wolf,et al.  Microaneurysm Turnover in Diabetic Retinopathy Assessed by Automated RetmarkerDR Image Analysis - Potential Role as Biomarker of Response to Ranibizumab Treatment , 2014, Ophthalmologica.

[18]  Aaron Y. Lee,et al.  The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group: Report 3: Baseline Retinopathy and Clinical Features Predict Progression of Diabetic Retinopathy. , 2017, American journal of ophthalmology.

[19]  Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group. , 1991, Ophthalmology.

[20]  Subhashini Venugopalan,et al.  Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs. , 2016, JAMA.

[21]  P. Scanlon The English National Screening Programme for diabetic retinopathy 2003–2016 , 2017, Acta Diabetologica.

[22]  Tien Yin Wong,et al.  Quantitative measurement of hard exudates in patients with diabetes and their associations with serum lipid levels. , 2013, Investigative ophthalmology & visual science.

[23]  M. Abràmoff,et al.  Validation of automated screening for referable diabetic retinopathy with the IDx‐DR device in the Hoorn Diabetes Care System , 2017, Acta ophthalmologica.

[24]  Tien Yin Wong,et al.  Diabetic retinopathy , 2010, The Lancet.

[25]  J. G. O'shea,et al.  Diabetic retinopathy. , 1995, Postgraduate medical journal.

[26]  E M Kohner,et al.  The effect of experimental hypertension on retinal vascular autoregulation in humans: a mechanism for the progression of diabetic retinopathy , 1995, Experimental physiology.

[27]  T. Bek Fine structure in diabetic retinopathy lesions as observed by adaptive optics imaging. A qualitative study , 2014, Acta ophthalmologica.

[28]  A. Keech,et al.  Biomarkers in Diabetic Retinopathy. , 2015, The review of diabetic studies : RDS.

[29]  J. Cunha-Vaz,et al.  Diabetic Retinopathy Phenotypes of Progression to Macular Edema: Pooled Analysis From Independent Longitudinal Studies of up to 2 Years' Duration. , 2017, Investigative ophthalmology & visual science.

[30]  M. L. Rasmussen,et al.  Microaneurysm count as a predictor of long-term progression in diabetic retinopathy in young patients with type 1 diabetes: the Danish Cohort of Pediatric Diabetes 1987 (DCPD1987) , 2014, Graefe's Archive for Clinical and Experimental Ophthalmology.

[31]  F. Wen,et al.  Venous beading in two or more quadrants might not be a sensitive grading criterion for severe nonproliferative diabetic retinopathy , 2018, Graefe's Archive for Clinical and Experimental Ophthalmology.

[32]  Stephen J. Aldington,et al.  Functional and Structural Findings of Neurodegeneration in Early Stages of Diabetic Retinopathy: Cross-sectional Analyses of Baseline Data of the EUROCONDOR Project , 2017, Diabetes.

[33]  Jennifer K. Sun,et al.  Peripheral Lesions Identified on Ultrawide Field Imaging Predict Increased Risk of Diabetic Retinopathy Progression over 4 Years. , 2015, Ophthalmology.

[34]  Matthew D. Davis,et al.  Comparison of digital and film grading of diabetic retinopathy severity in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. , 2011, Archives of ophthalmology.

[35]  Jennifer K. Sun,et al.  Side-Effects and Complications of Laser Treatment in Diabetic Retinal Disease , 2014, Seminars in ophthalmology.

[36]  T. Wong,et al.  Retinal vessel diameter as a clinical predictor of diabetic retinopathy progression: time to take out the measuring tape. , 2011, Archives of ophthalmology.

[37]  P F Sharp,et al.  Cost-effectiveness of implementing automated grading within the national screening programme for diabetic retinopathy in Scotland , 2007, British Journal of Ophthalmology.

[38]  Dawn A Sim,et al.  Automated Retinal Image Analysis for Diabetic Retinopathy in Telemedicine , 2015, Current Diabetes Reports.

[39]  Ihsan Ul Haq,et al.  Automated System for Referral of Cotton-Wool Spots. , 2018, Current diabetes reviews.

[40]  E. Stefánsson,et al.  Individualised risk assessment for diabetic retinopathy and optimisation of screening intervals: a scientific approach to reducing healthcare costs , 2015, British Journal of Ophthalmology.

[41]  T Bek,et al.  The regional distribution of diabetic retinopathy lesions may reflect risk factors for progression of the disease. , 2001, Acta ophthalmologica Scandinavica.

[42]  E. Stefánsson,et al.  Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy , 2011, Diabetologia.

[43]  A. Kampik,et al.  Correlation of leaking microaneurysms with retinal thickening in diabetic retinopathy. , 2011, International journal of ophthalmology.

[44]  T. Curtis,et al.  Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis? , 2009, Eye.